Becton Dickinson (BDX) vs Solventum (SOLV)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Becton Dickinson (BDX) has outperformed Solventum (SOLV) over the past year, gaining 19.0% versus a gain of 19.0%. Becton Dickinson is the larger company by market cap ($49.07 billion vs $14.62 billion), about 3.4 times the size. On valuation, Solventum trades at a lower forward P/E (11.9x vs 13.5x for Becton Dickinson).
Becton Dickinson pays a dividend yielding 2.33%, while Solventum does not currently pay one. Solventum converts more of its revenue into profit, with a net margin of 18.7% versus 7.7%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | BDX | SOLV |
|---|---|---|
| Share price | $180.16 | $85.88 |
| Market cap | $49.07B | $14.62B |
| 1-day change | -0.08% | -1.33% |
| YTD return | +18.08% | +8.38% |
| 1-year return | +19.03% | +19.01% |
| 5-year return | -2.60% | — |
| P/E ratio (TTM) | 41.90 | 10.66 |
| Forward P/E | 13.54 | 11.88 |
| EPS (TTM) | $4.30 | $8.06 |
| Dividend yield | 2.33% | 0.00% |
| Annual dividend | $4.19 | $0.00 |
| Revenue (latest FY) | $21.84B | $8.32B |
| Revenue growth (YoY) | +8.24% | +0.86% |
| Net income (latest FY) | $1.68B | $1.56B |
| Gross margin | 45.44% | 53.47% |
| Operating margin | 11.81% | 26.20% |
| Net margin | 7.68% | 18.69% |
| 52-week high | $193.07 | $94.16 |
| 52-week low | $127.59 | $62.38 |
| Distance from 52-week high | -6.69% | -8.79% |
| Analyst consensus | buy | buy |
| Avg. price target upside | +7.73% | +9.82% |
| Average volume | 1.78M | 1.02M |
| Shares outstanding | 272.39M | 170.22M |
| Employees | 72,000 | 20,584 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Becton Dickinson is about 3.4 times larger than Solventum by market value ($49.07B vs $14.62B).
- Becton Dickinson trades at a higher earnings multiple (41.9x vs 10.7x trailing P/E).
- Becton Dickinson offers a meaningfully higher dividend yield (2.33% vs 0.00%).
- Solventum is more profitable, keeping 18.7 cents of every revenue dollar as net income versus 7.7 cents for Becton Dickinson.
- Becton Dickinson grew revenue faster in its latest fiscal year (+8.24% vs +0.86%).
About Becton Dickinson
BDX stock →Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. It operates through Medical Essentials, Connected Care, BioPharma Systems, Interventional and Life Sciences segments.
Health Care · Medical/Dental Instruments · 72,000 employees
About Solventum
SOLV stock →Solventum Corporation, a healthcare company, develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs in the United States and internationally. It operates through three segments: Medsurg, Dental Solutions, and Health Information Systems.
Health Care · Medical/Dental Instruments · 20,584 employees
BDX vs SOLV FAQ
Which is bigger, Becton Dickinson or Solventum?
Becton Dickinson (BDX) is larger, with a market capitalization of $49.07B compared with $14.62B for Solventum (SOLV).
Which stock has performed better over the past year, BDX or SOLV?
BDX returned +19.03% over the past 12 months, compared with +19.01% for SOLV (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, BDX or SOLV?
SOLV has the lower trailing P/E at 10.7, versus 41.9 for BDX. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Which pays a higher dividend, Becton Dickinson or Solventum?
Becton Dickinson pays a dividend yielding 2.33%, while Solventum does not currently pay a regular dividend.
Are Becton Dickinson and Solventum in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.